European standard clinical practice recommendations for newly diagnosed ependymoma of childhood and adolescence

No abstract is available for this paper.

• Publication year

  2025

• Venue

  EJC Paediatric Oncology

• Publication date

  2025-04-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.ejcped.2025.100227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Anaplastic histology and distinct molecular features in a small series of spinal cord ependymomas

  2024cited by this paper
• Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: a multicenter study.

  2023cited by this paper
• Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.

  2022cited by this paper
• Toward Improved Diagnosis Accuracy and Treatment of Children, Adolescents, and Young Adults With Ependymoma: The International SIOP Ependymoma II Protocol

  2022cited by this paper
• Optimizing biomarkers for accurate ependymoma diagnosis, prognostication, and stratification within International Clinical Trials: A BIOMECA study

  2022cited by this paper
• Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease.

  2022cited by this paper
• OUP accepted manuscript

  2022cited by this paper
• The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

  2021cited by this paper
• European Society for Paediatric Oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours

  2021cited by this paper
• Cross-species genomics reveals oncogenic dependencies in ZFTA/C11orf95 fusion-positive supratentorial ependymomas.

  2021cited by this paper
• Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.

  2021cited by this paper
• Proton Therapy for Pediatric Ependymoma: Mature Results from a Bicentric Study.

  2021cited by this paper
• Proton RBE models: commonalities and differences

  2021cited by this paper
• EPEN-54. ACNS0831, PHASE III RANDOMIZED TRIAL OF POST-RADIATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED EPENDYMOMA AGES 1 TO 21 YEARS

  2020cited by this paper
• A retrospective analysis of recurrent pediatric ependymoma reveals extremely poor survival and ineffectiveness of current treatments across central nervous system locations and molecular subgroups

  2020cited by this paper
• cIMPACT‐NOW update 7: advancing the molecular classification of ependymal tumors

  2020cited by this paper
• High level MYCN amplification and distinct methylation signature define an aggressive subtype of spinal cord ependymoma

  2020cited by this paper
• CDKN2A deletion in supratentorial ependymoma with RELA alteration indicates a dismal prognosis: a retrospective analysis of the HIT ependymoma trial cohort

  2020cited by this paper
• Molecular characterization of histopathological ependymoma variants

  2020cited by this paper
• Long-Term Surgical Resection Outcomes of Pediatric Myxopapillary Ependymoma: Experience of Two Centers and Brief Literature Review.

  2019cited by this paper
• Molecular Grouping and Outcomes of Young Children with Newly Diagnosed Ependymoma Treated on the Multi-Institutional SJYC07 Trial.

  2019cited by this paper
• Spinal Cord Ependymomas With MYCN Amplification Show Aggressive Clinical Behavior.

  2019cited by this paper
• MYCN amplification drives an aggressive form of spinal ependymoma

  2019cited by this paper
• Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT Series.

  2019cited by this paper
• Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma.

  2019cited by this paper
• Pediatric Supratentorial Ependymoma: Surgical, Clinical, and Molecular Analysis.

  2018cited by this paper
• Ependymomas arising outside of the central nervous system: A case series and literature review.

  2018cited by this paper
• Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee

  2018cited by this paper
• C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin

  2018cited by this paper
• Pediatric extraspinal sacrococcygeal ependymoma (ESE): an Italian AIEOP experience of six cases and literature review

  2018cited by this paper
• Significance of molecular classification of ependymomas: C11orf95-RELA fusion-negative supratentorial ependymomas are a heterogeneous group of tumors

  2018cited by this paper
• Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging

  2018cited by this paper
• Childhood supratentorial ependymomas with YAP1‐MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features

  2018cited by this paper
• DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment

  2018cited by this paper
• Heterogeneity within the PF-EPN-B ependymoma subgroup

  2018cited by this paper
• Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas

  2018cited by this paper
• Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology

  2017cited by this paper
• Outcomes following proton therapy for pediatric ependymoma

  2017cited by this paper
• Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome

  2017cited by this paper
• Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas

  2016cited by this paper
• The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants

  2016cited by this paper
• Supratentorial clear cell ependymomas with branching capillaries demonstrate characteristic clinicopathological features and pathological activation of nuclear factor-kappaB signaling.

  2016cited by this paper
• Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.

  2016cited by this paper
• Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network.

  2015cited by this paper
• Myxopapillary ependymomas in children: imaging, treatment and outcomes

  2015cited by this paper
• Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.

  2015cited by this paper
• Supratentorial ependymomas of childhood carry C11orf95–RELA fusions leading to pathological activation of the NF-κB signaling pathway

  2014cited by this paper
• C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma

  2014cited by this paper
• Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review.

  2013cited by this paper
• Clinical Investigation : Pediatric Cancer Management of Pediatric Myxopapillary Ependymoma : The Role of Adjuvant Radiation

  2013cited by this paper
• Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.

  2013cited by this paper
• Spinal cord ependymoma in children--results of postoperative radiotherapy.

  2013cited by this paper
• A systematic review of treatment outcomes in pediatric patients with intracranial ependymomas.

  2013cited by this paper
• Outcome of infants and young children with newly diagnosed ependymoma treated on the “Head Start” III prospective clinical trial

  2013cited by this paper
• A 5-year investigation of children's adaptive functioning following conformal radiation therapy for localized ependymoma.

  2012cited by this paper
• Spinal cord ependymomas in children and adolescents

  2012cited by this paper
• Distinct disease-risk groups in pediatric supratentorial and posterior fossa ependymomas

  2012cited by this paper
• Phase II study of pre‐irradiation chemotherapy for childhood intracranial ependymoma. Children's Cancer Group protocol 9942: A report from the Children's Oncology Group

  2012cited by this paper
• Metastatic Medulloblastoma in Childhood: Chang's Classification Revisited

  2011cited by this paper
• Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.

  2011cited by this paper
• Infant ependymoma in a 10-year AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) experience with omitted or deferred radiotherapy.

  2011cited by this paper
• Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma.

  2011cited by this paper
• Neurofibromatosis-2 and spinal cord ependymomas: Report of two cases and review of the literature

  2011cited by this paper
• Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database.

  2010cited by this paper
• Neuroradiologic Review in Pediatric Brain Tumor Studies

  2009cited by this paper
• Intracranial ependymomas in children: society of pediatric oncology experience with postoperative hyperfractionated local radiotherapy.

  2009cited by this paper
• Three-dimensional conformal radiation therapy for ependymoma

  2009cited by this paper
• Conformal radiotherapy after surgery for paediatric ependymoma: a prospective study.

  2009cited by this paper
• Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study.

  2009cited by this paper
• Metastatic ependymoma: A multi‐institutional retrospective analysis of prognostic factors

  2008cited by this paper
• The results of surgery, with or without radiotherapy, for primary spinal myxopapillary ependymoma: a retrospective study from the rare cancer network.

  2008cited by this paper
• The prognostic value of histological grading of posterior fossa ependymomas in children: a Children's Oncology Group study and a review of prognostic factors

  2008cited by this paper
• Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue

  2007cited by this paper
• Primary postoperative chemotherapy without radiotherapy for intracranial ependymoma in children: the UKCCSG/SIOP prospective study.

  2007cited by this paper
• Spinal cord gliomas: A multi-institutional retrospective analysis.

  2006cited by this paper
• Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.

  2005cited by this paper
• Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.

  2005cited by this paper
• Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92.

  2005cited by this paper
• Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.

  2004cited by this paper
• Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.

  2001cited by this paper
• Low Frequency of Chromosomal Imbalances in Anaplastic Ependymomas as Detected by Comparative Genomic Hybridization

  2001cited by this paper
• Combined postoperative irradiation and chemotherapy for anaplastic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91.

  2000cited by this paper
• Chemotherapy for intracranial ependymomas

  1999cited by this paper
• Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation.

  1998cited by this paper
• Postoperative Chemotherapy in Children Less Than 4 Years of Age with Malignant Brain Tumors: Promising Initial Response to a VETOPEC‐Based Regimen A Study of the Australian and New Zealand Children's Cancer Study Group (ANZCCSG)

  1998cited by this paper
• Prognostic Factors in Infants and Very Young Children with Intracranial Ependymomas

  1998cited by this paper
• Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.

  1997cited by this paper
• An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas.

  1969cited by this paper
• ependymoma: reproducibility and clinical relevance in European trial cohorts

  year unknowncited by this paper

• Spanish Paediatric Haematology and Oncology Survival Results and Trends, 1999–2022

  2026cites this paper
• Precision Neuro-Oncology in Glioblastoma: AI-Guided CRISPR Editing and Real-Time Multi-Omics for Genomic Brain Surgery

  2025cites this paper
• Ependymal Tumors.

  2025cites this paper